Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells. Issue 17 (1st September 2019)
- Record Type:
- Journal Article
- Title:
- Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells. Issue 17 (1st September 2019)
- Main Title:
- Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells
- Authors:
- Mullarky, Edouard
Xu, Jiayi
Robin, Anita D.
Huggins, David J.
Jennings, Andy
Noguchi, Naoyoshi
Olland, Andrea
Lakshminarasimhan, Damodharan
Miller, Michael
Tomita, Daisuke
Michino, Mayako
Su, Taojunfeng
Zhang, Guoan
Stamford, Andrew W.
Meinke, Peter T.
Kargman, Stacia
Cantley, Lewis C. - Abstract:
- Graphical abstract: Abstract: Cancer cells reprogram their metabolism to support growth and to mitigate cellular stressors. The serine synthesis pathway has been identified as a metabolic pathway frequently altered in cancers and there has been considerable interest in developing pharmacological agents to target this pathway. Here, we report a series of indole amides that inhibit human 3-phosphoglycerate dehydrogenase (PHGDH), the enzyme that catalyzes the first committed step of the serine synthesis pathway. Using X-ray crystallography, we show that the indole amides bind the NAD + pocket of PHGDH. Through structure-based optimization we were able to develop compounds with low nanomolar affinities for PHGDH in an enzymatic IC50 assay. In cellular assays, the most potent compounds inhibited de novo serine synthesis with low micromolar to sub-micromolar activities and these compounds successfully abrogated the proliferation of cancer cells in serine free media. The indole amide series reported here represent an important improvement over previously published PHGDH inhibitors as they are markedly more potent and their mechanism of action is better defined.
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 29:Issue 17(2019)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 29:Issue 17(2019)
- Issue Display:
- Volume 29, Issue 17 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 17
- Issue Sort Value:
- 2019-0029-0017-0000
- Page Start:
- 2503
- Page End:
- 2510
- Publication Date:
- 2019-09-01
- Subjects:
- PHGDH -- 3-Phosphoglycerate dehydrogenase -- Serine synthesis -- Cancer metabolism -- PHGDH inhibitor -- Inhibitor
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2019.07.011 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11385.xml